OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 114 ( 10 ) ISSN 0027-8424

Significance HIV infection can be restricted by different host cell proteins. One such restriction factor is SAM domain and HD domain-containing protein 1 (SAMHD1), a triphosphohydrolase that cleaves dNTPs, which are required for HIV reverse transcription. The accessory lentiviral protein X (Vpx) from simian immunodeficiency viruses (SIV) of sooty mangabeys and rhesus macaques or from HIV-2 degrade SAMHD1. Here we show that Vpx proteins from SIVs of red-capped mangabeys and mandrills enhance HIV infection of resting CD4 T cells, but not macrophages, without affecting levels of either SAMHD1 or dNTPs. These Vpx proteins overcome a previously unrecognized SAMHD1-independent, cell-type–specific restriction at the level of reverse transcription and highlight the plasticity of lentiviruses to counteract the innate immune system. Early after entry into monocytes, macrophages, dendritic cells, and resting CD4 T cells, HIV encounters a block, limiting reverse transcription (RT) of the incoming viral RNA genome. In this context, dNTP triphosphohydrolase SAM domain and HD domain-containing protein 1 (SAMHD1) has been identified as a restriction factor, lowering the concentration of dNTP substrates to limit RT. The accessory lentiviral protein X (Vpx) proteins from the major simian immunodeficiency virus of rhesus macaque, sooty mangabey, and HIV-2 (SIVsmm/SIVmac/HIV-2) lineage packaged into virions target SAMHD1 for proteasomal degradation, increase intracellular dNTP pools, and facilitate HIV cDNA synthesis. We find that virion-packaged Vpx proteins from a second SIV lineage, SIV of red-capped mangabeys or mandrills (SIVrcm/mnd-2), increased HIV infection in resting CD4 T cells, but not in macrophages, and, unexpectedly, acted in the absence of SAMHD1 degradation, dNTP pool elevation, or changes in SAMHD1 phosphorylation. Vpx rcm/mnd-2 virion incorporation resulted in a dramatic increase of HIV-1 RT intermediates and viral cDNA in infected resting CD4 T cells. These analyses also revealed a barrier limiting HIV-1 infection of resting CD4 T cells at the level of nuclear import. Single amino acid changes in the SAMHD1-degrading Vpx mac239 allowed it to enhance early postentry steps in a Vpx rcm/mnd-2–like fashion. Moreover, Vpx enhanced HIV-1 infection of SAMHD1-deficient resting CD4 T cells of a patient with Aicardi-Goutières syndrome. These results indicate that Vpx, in addition to SAMHD1, overcomes a previously unappreciated restriction for lentiviruses at the level of RT that acts independently of dNTP concentrations and is specific to resting CD4 T cells.

[1]  T. Hope,et al.  HIV-1 capsid: the multifaceted key player in HIV-1 infection , 2015, Nature Reviews Microbiology.

[2]  Jinming Zhou,et al.  Characterization of the interactions between SIVrcm Vpx and red-capped mangabey SAMHD1. , 2015, The Biochemical journal.

[3]  I. Taylor,et al.  Molecular Determinants for Recognition of Divergent SAMHD1 Proteins by the Lentiviral Accessory Protein Vpx , 2015, Cell host & microbe.

[4]  F. Lasitschka,et al.  SAMHD1's protein expression profile in humans , 2015, Journal of leukocyte biology.

[5]  C. Aiken,et al.  HIV-1 uncoating: connection to nuclear entry and regulation by host proteins. , 2014, Virology.

[6]  M. Malim,et al.  New insights into an X-traordinary viral protein , 2014, Front. Microbiol..

[7]  I. Taylor,et al.  Structural basis of lentiviral subversion of a cellular protein degradation pathway , 2013, Nature.

[8]  J. Luban,et al.  Vpx rescue of HIV-1 from the antiviral state in mature dendritic cells is independent of the intracellular deoxynucleotide concentration , 2014, Retrovirology.

[9]  O. Fackler Restrictions to HIV-1 replication in resting CD4+ T lymphocytes , 2013, Retrovirology.

[10]  Michael Emerman,et al.  Evolutionary Toggling of Vpx/Vpr Specificity Results in Divergent Recognition of the Restriction Factor SAMHD1 , 2013, PLoS pathogens.

[11]  Hanna-Mari Baldauf,et al.  Restrictions to HIV-1 replication in resting CD4+ T lymphocytes , 2013, Cell Research.

[12]  M. Benkirane,et al.  Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. , 2013, Cell reports.

[13]  Baek Kim,et al.  The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. , 2013, Cell host & microbe.

[14]  R. König,et al.  SAMHD1 restricts HIV-1 infection in resting CD4+ T cells , 2012, Nature Medicine.

[15]  Y. Crow,et al.  SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells , 2012, Retrovirology.

[16]  O. Schwartz,et al.  Restricting HIV the SAMHD1 way: through nucleotide starvation , 2012, Nature Reviews Microbiology.

[17]  Baek Kim,et al.  Tight Interplay among SAMHD1 Protein Level, Cellular dNTP Levels, and HIV-1 Proviral DNA Synthesis Kinetics in Human Primary Monocyte-derived Macrophages* , 2012, The Journal of Biological Chemistry.

[18]  Michael Emerman,et al.  The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. , 2012, Cell host & microbe.

[19]  Baek Kim,et al.  SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates , 2012, Nature Immunology.

[20]  R. König,et al.  SAMHD1-Deficient CD14+ Cells from Individuals with Aicardi-Goutières Syndrome Are Highly Susceptible to HIV-1 Infection , 2011, PLoS pathogens.

[21]  Geoff Kelly,et al.  HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase , 2011, Nature.

[22]  B. Sobhian,et al.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.

[23]  M. Washburn,et al.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.

[24]  J. Luban,et al.  Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon , 2011, Retrovirology.

[25]  N. Bhardwaj,et al.  Human Immunodeficiency Virus Type 1 Modified To Package Simian Immunodeficiency Virus Vpx Efficiently Infects Macrophages and Dendritic Cells , 2011, Journal of Virology.

[26]  T. Gramberg,et al.  Evidence for an Activation Domain at the Amino Terminus of Simian Immunodeficiency Virus Vpx , 2009, Journal of Virology.

[27]  Rajnish Kaushik,et al.  A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. , 2009, Cell host & microbe.

[28]  A. Bergamaschi,et al.  The Human Immunodeficiency Virus Type 2 Vpx Protein Usurps the CUL4A-DDB1DCAF1 Ubiquitin Ligase To Overcome a Postentry Block in Macrophage Infection , 2009, Journal of Virology.

[29]  M. Mcclure,et al.  A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. , 2009, Journal of virological methods.

[30]  J. Luban,et al.  Characterization of Simian Immunodeficiency Virus SIVSM/Human Immunodeficiency Virus Type 2 Vpx Function in Human Myeloid Cells , 2008, Journal of Virology.

[31]  M. Otsuka,et al.  Vpx Is Critical for Reverse Transcription of the Human Immunodeficiency Virus Type 2 Genome in Macrophages , 2008, Journal of Virology.

[32]  Smita Srivastava,et al.  Lentiviral Vpx Accessory Factor Targets VprBP/DCAF1 Substrate Adaptor for Cullin 4 E3 Ubiquitin Ligase to Enable Macrophage Infection , 2008, PLoS pathogens.

[33]  C. June,et al.  Addition of Deoxynucleosides Enhances Human Immunodeficiency Virus Type 1 Integration and 2LTR Formation in Resting CD4+ T Cells , 2007, Journal of Virology.

[34]  O. Keppler,et al.  HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription , 2007, Proceedings of the National Academy of Sciences.

[35]  J. Darlix,et al.  Retrovirology BioMed Central , 2006 .

[36]  W. Greene,et al.  Rodent Cells Support Key Functions of the Human Immunodeficiency Virus Type 1 Pathogenicity Factor Nef , 2005, Journal of Virology.

[37]  R. Bambara,et al.  Macrophage Tropism of HIV-1 Depends on Efficient Cellular dNTP Utilization by Reverse Transcriptase* , 2004, Journal of Biological Chemistry.

[38]  P. Charneau,et al.  The Maturation of Dendritic Cells Results in Postintegration Inhibition of HIV-1 Replication1 , 2001, The Journal of Immunology.

[39]  M. Emerman,et al.  Vpx association with mature core structures of HIV-2. , 1996, Virology.

[40]  X. Yu,et al.  The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage , 1991, Journal of virology.

[41]  M. Stevenson,et al.  HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.

[42]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.